Roesler W J, Khandelwal R L
Endocrinology. 1987 Jul;121(1):227-32. doi: 10.1210/endo-121-1-227.
The concentrations of glycogen phosphorylase protein were determined by rocket immunoelectrophoresis in liver extracts from rats that had artificially induced altered hormonal patterns. These levels were compared with measurements of total phosphorylase activity. Minipump-induced chronic hyperglucagonemia and streptozotocin-induced diabetes resulted in 47% and 67% decreases, respectively, in total phosphorylase activity along with corresponding 52% and 68% drop, respectively, in phosphorylase protein levels. Insulin replacement in diabetic rats returned both parameters to control values. Minipump-induced hyperinsulinemia or injection of glucagon antiserum, T3, or propylthiouracil had no effect. The results of this study indicate that conditions which lead to an elevation of the glucagon to insulin molar ratio to values higher than 1.0 cause a significant decrease in the liver phosphorylase protein level.
通过火箭免疫电泳法测定了人工诱导激素模式改变的大鼠肝脏提取物中糖原磷酸化酶蛋白的浓度。将这些水平与总磷酸化酶活性的测量值进行比较。微型泵诱导的慢性高胰高血糖素血症和链脲佐菌素诱导的糖尿病分别导致总磷酸化酶活性降低47%和67%,同时磷酸化酶蛋白水平分别相应下降52%和68%。给糖尿病大鼠补充胰岛素可使这两个参数恢复到对照值。微型泵诱导的高胰岛素血症或注射胰高血糖素抗血清、T3或丙硫氧嘧啶均无影响。本研究结果表明,导致胰高血糖素与胰岛素摩尔比升高至高于1.0的情况会导致肝脏磷酸化酶蛋白水平显著降低。